KUNMING LONGJIN PHARMACEUTICAL CO., LTD.

Andere talen Kunming Longjin Pharmaceutical Co., Ltd.

Aandelen

002750

CNE1000021X8

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,67 ^CNY	-4,92%		-19,34%	-63,30%

29/04	Kunming Longjin Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
29/04	Kunming Longjin Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Kunming Longjin Pharmaceutical Co., Ltd. Approves Board Elections	04/01
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20-04-23
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27-10-22
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25-08-22
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29-04-22
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	29-04-22
Kunming Longjin Pharmaceutical's Shareholder Plans to Cut 6% Stake	12-01-22
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28-10-21
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30-08-21
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021	27-04-21
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	14-04-21
Longjin Approves Election of Directors	04-01-21
Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	28-10-20
Yunnan Longjin Fantian Biological Technology Co., Ltd. announced that it has received CNY 48 million in funding from Kunming Longjin Pharmaceutical Co., Ltd.	21-09-20
Yunnan Longjin Fantian Biological Technology Co., Ltd. announced that it expects to receive CNY 48 million in funding from Kunming Longjin Pharmaceutical Co., Ltd.	01-09-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kunming Longjin Pharmaceutical Co., Ltd.

Aandelen

002750

CNE1000021X8

Andere talen

Filters